Search Within

Population Sciences Research Program

  1. "Alison Moskowitz"
  2. "Dermatology Service"
Formats
  1. Journal Article (23)
  2. Meeting Abstract (23)
  3. Review (3)
  4. Research Letter (2)
  5. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (52)
  2. Department of Medicine (52)
  3. Dermatology (52)
  4. Dermatology Service (52)
  5. Division of Subspecialty Medicine (52)
  6. Hematologic Malignancies, Division of (52)

More Groups

People
  1. Alison Moskowitz (52)
  2. Patricia Myskowski (52)
  3. Steven Horwitz (52)
  4. Melissa Pulitzer (29)
  5. Christiane Querfeld (15)
  6. Shamir Geller (14)

More People

Years
  1. 2023 (2)
  2. 2022 (1)
  3. 2021 (8)
  4. 2020 (4)
  5. 2019 (7)
  6. 2018 (8)

More Years

Publications
  1. Blood (15)
  2. Journal of the American Academy of Dermatology (12)
  3. Journal of Clinical Oncology (3)
  4. Hematological Oncology (2)
  5. Journal of Investigative Dermatology (2)
  6. American Journal of Dermatopathology (1)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. Mosby Elsevier (12)
  3. Wiley Blackwell (6)
  4. American Society of Clinical Oncology (3)
  5. American Association for Cancer Research (2)
  6. Elsevier Inc. (2)

More Publishers

Results (52)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
    Meeting Abstract

    Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Johnson, W.; Moskowitz, A.; Myskowski, P.; Pulitzer, M.; Horwitz, S. M.; Geller, S.
    Blood (2023)

    Fulltext@MSK | Save
  • Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability
    Meeting Abstract

    Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The potential for technology to aid quantitative assessment in cutaneous T cell lymphoma
    Correspondence

    Gu, L.; Oh, Y.; Smith, M. P.; Kurtansky, N. R.; Horwitz, S.; Kahn, N.; Moskowitz, A.; Noor, S. J.; Myskowski, P.; Rotemberg, V.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Clinical outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg type treated in the rituximab era: Long-term follow-up of a single-center experience
    Meeting Abstract

    Falchi, L.; Qiu, A.; Ewalt, M. D.; Batlevi, C. L.; Caron, P. C.; Hamlin, P. A.; Hamilton, A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
    Journal Article

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Vardhana, S.; Ganesan, N.; Hancock, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis
    Review

    Stoll, J. R.; Willner, J.; Oh, Y.; Pulitzer, M.; Moskowitz, A.; Horwitz, S.; Myskowski, P.; Noor, S. J.
    Journal of the American Academy of Dermatology (2021)

    Fulltext@MSK | Save
  • Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management
    Review

    Oh, Y.; Stoll, J. R.; Moskowitz, A.; Pulitzer, M.; Horwitz, S.; Myskowski, P.; Noor, S. J.
    Journal of the American Academy of Dermatology (2021)

    Fulltext@MSK | Save
  • Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts
    Journal Article

    Mehta-Shah, N.; Lunning, M. A.; Moskowitz, A. J.; Boruchov, A. M.; Ruan, J.; Lynch, P.; Hamlin, P. A.; Leonard, J.; Matasar, M. J.; Myskowski, P. L.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Lymphomatoid papulosis: A retrospective review of clinical characteristics, symptomatology, treatments, and associated malignancies at a single institution
    Meeting Abstract

    Stoll, J.; Pulitzer, M.; Moskowitz, A.; Horwitz, S.; Myskowski, P. L.; Noor, S. J.
    Journal of the American Academy of Dermatology (2021)

    Fulltext@MSK | Save
  • A phase II trial of reduced dose brentuximab vedotin for cutaneous T‐cell lymphomas
    Meeting Abstract

    Khan, N.; Noor, S.; Geller, S.; Khodadoust, M. S.; Kheterpal, M.; Hancock, H.; Davey, T.; Ryu, S.; Perez, L.; Lares, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save